Galapagos to Start Trial Testing New Triple-Combo Therapy for CF
Galapagos is starting a clinical trial called FALCON to evaluate a new triple-combination therapy to treat cystic fibrosis patients. The...
Abnormal Glucose Levels Linked to Poorer Lung Function in Cystic Fibrosis Youth, Study Shows
Abnormalities in continuous glucose monitoring (CGM) measures correlate with a decline in lung function in children and adolescents with...
2 Urine Biomarkers Can Help Detect Aminoglycosides-induced Kidney Damage in CF Patients, Study Sugge
Quantification of two specific molecules in urine can help in the early detection of kidney damage triggered by treatment with...
Many CF Patients Have Long-term Staphylococcus Aureus Infections, Study Shows
Many cystic fibrosis patients have long-term Staphylococcus aureus infections, with the bacteria’s resistance to antibiotics fluctuating...
GeneFo Releases Updated 2018 Guide to Help Cystic Fibrosis Patients Navigate Treatment Options
GeneFo has put together an updated 2018 guide on treatment options for people with cystic fibrosis (CF) after recent developments again...
Eluforsen for cystic fibrosis
ProQR is developing an investigational product, eluforsen (QR-010) for people with cystic fibrosis (CF) that have the F508del mutation....